Gordian Surgical Overview
Gordian Surgical is the developer of the TroClose 1200, an integrated port closure system offering surgeons a simple, secure, and safe solution for opening and suturing closed the abdominal wall during laparoscopic procedures. The device is compatible with all types of trocars. Instead of inserting closure sutures into the fascia at the end of a procedure, Gordians uniquely designed two in one obturator and cannula efficiently inserts absorbable sutures into the peritoneal tissue surrounding the cannula at the beginning of the procedure. Two absorbable anchors hold the suture in place, and when the cannula is removed, the surgeon can close the fascia by simply tying the TroClose 1200 sutures together.
Cumulative Funding Raised Over Time ($)
Latest News
growth-positive
Gordian Surgical's Closure System Used in Panama by PanaFarma
Gordian Surgicals exclusive distributor in Panama, PanaFarma, has won a tender to supply Panamas social security hospitals with the TroClose 1200 access-closure system for a two-year period. This translates to the sale of a few thousand products to Panama. The TroClose 1200 is a port access-closure system for laparoscopic surgery that offers surgeons a simple, secure, and safe solution to open and close the abdominal wall. Gordian Surgical is a commercial-stage medical device company with growing international sales. CEO Zvi Peer expressed excitement about the cooperation with PanaFarma and the potential market reach in countries with larger populations.
Customers
growth-positive
Gordian Surgical wins FDA clearance, raises $2m for TroClose1200
Gordian Surgical, a portfolio company of Trendlines Medical, has received FDA clearance for its TroClose 1200 trocar, which is used in laparoscopic surgery. The company also announced the closure of a $2.3 million funding round led by B. Braun. The funding will allow Gordian Surgical to move towards commercialization of its device in the USA, Europe, and other markets. The TroClose 1200 has already received CE Mark certification in the European Union and has shown promising results in post-market surveillance studies. The investment by B. Braun is based on the unique design of the TroClose1200 and the potential in the global laparoscopic market. Gordian Surgical plans to save time for surgeons and reduce anesthesia time for patients with its integrated closure/trocar device.
Investment
growth-positive
TroClose1200 Trocar With Built-In Sutures for Rapid Closure of Abdominal Wall
Gordian Surgical, an Israeli company, has received the European CE mark for its TroClose1200 laparoscopy trocar with a built-in suturing system. The company aims to save surgeons time by eliminating the need for manual suturing or additional devices to close incisions. Gordian Surgical is currently conducting clinical trials to demonstrate the effectiveness of its technology, with 34 procedures already completed and 50 more planned. The companys device has been used in various medical procedures such as hysterectomy, cholecystectomy, hernia repair, and sleeve gastrectomy.
Customers
growth-positive
Gordian Surgical launches 1st-in-human trials of TroClose 1200
Gordian Surgical, a portfolio company of Trendlines Medical, has launched 1st-in-human trials for its TroClose 1200 trocar. The device is designed to enable access to the abdomen during laparoscopic surgery and close incisions in the abdominal wall. The TroClose 1200 uses a novel closure system with sutures that are inserted into the tissue at the beginning of the procedure and automatically tightened and closed when the device is removed. The trials have received positive feedback from medical professionals. Gordian Surgical previously raised nearly $1 million in funding, with Virtus Inspire Ventures as one of the investors. The company plans to conduct further procedures and follow-up trials to confirm the products functionality.
Investment
growth-positive
Israeli laparoscopy co Gordian Surgical raises $1m
Gordian Surgical, an Israeli laparoscopy surgical developer, has raised nearly $1 million in funding. The investment comes from Virtus Inspire Ventures, a Chinese venture capital firm, as well as leading US laparoscopic surgeons and other investors. Gordian Surgical will use the funds to complete regulatory processes, start clinical trials, and prepare for market penetration. The company has developed an innovative trocar that simplifies the process of closing internal incisions made during laparoscopic surgery. Despite the more than 10 million laparoscopic surgeries performed worldwide, closing abdominal incisions remains time-consuming and poses risks of complications. The investment demonstrates confidence in Gordian Surgicals team and the market potential of its products.
Investment
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | $8.7M |
| Last funding | $3M |
| Stage | Mature |
| Rounds | 6 |
| Investors | 6 |
Team Members
2
Employees: 1-10
Web & Social Links
| Website | www.gordiansurgical.com |
Locations
17 Tchelet St., Misgav, Israel
33 North Mall, Plainview, NY 11803, USA
Photos & Videos
4 item(s)
